You just read:

Emmaus Life Sciences, Inc. Receives Notice of Allowance for Japanese Patent for use of L-glutamine in Treatment of Diabetes

News provided by

Emmaus Life Sciences, Inc.

07 Feb, 2017, 08:00 ET